Redeye: Navigo Invest Q2 2024 - Recovery in sight
Redeye updates its estimates and valuation after Navigo’s Q2 2024 report. Second-quarter figures slightly missed our sales estimates but beat our adjusted profitability projections. We expect weak H1 cash flow to recover in H2 2024e. Nordisk Bergteknik’s share price increase and updated estimates as well as peer multiples fuel an upgrade in our valuation.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/